1.1 EL IMPACTO DE LAS TECNOLOGÍAS DE LA INFORMACIÓN EN RETAIL
1.1.3 ADVANCED ANALYTICS
2204
treated in a German hospital, October-November 2012. Euro. Surveill. 18. pii 20406. 2205
184. Spanakis N, Tsiodras S, Haagmans BL, Raj VS, Pontikis K, Koutsoukou A,
2206
Koulouris NG, Osterhaus AD, Koopmans MP, Tsakris A. 2014. Virological and
2207
serological analysis of a recent Middle East respiratory syndrome coronavirus infection 2208
case on a triple combination antiviral regimen. Int. J. Antimicrob. Agents 44:528-532. 2209
185. Tao X, Hill TE, Morimoto C, Peters CJ, Ksiazek TG, Tseng CT. 2013. Bilateral entry
2210
and release of Middle East respiratory syndrome coronavirus induces profound apoptosis 2211
of human bronchial epithelial cells. J. Virol. 87:9953-9958. 2212
186. Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M,
2213
Becker S, Weber F. 2013. Human cell tropism and innate immune system interactions of
2214
human respiratory coronavirus EMC compared to those of severe acute respiratory 2215
syndrome coronavirus. J. Virol. 87:5300-5304. 2216
187. Kindler E, Jonsdottir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R,
2217
Geffers R, Fouchier RA, Drosten C, Muller MA, Dijkman R, Thiel V. 2013. Efficient
2218
replication of the novel human betacoronavirus EMC on primary human epithelium 2219
highlights its zoonotic potential. mBio 4:e00611-00612. 2220
188. Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD,
2221
Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS. 2013.
2222
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory 2223
syndrome coronavirus. Proc. Natl. Acad. Sci. U. S. A. 110:16157-16162. 2224
189. Hocke AC, Becher A, Knepper J, Peter A, Holland G, Tonnies M, Bauer TT,
2225
Schneider P, Neudecker J, Muth D, Wendtner CM, Ruckert JC, Drosten C, Gruber
2226
AD, Laue M, Suttorp N, Hippenstiel S, Wolff T. 2013. Emerging human middle East
2227
respiratory syndrome coronavirus causes widespread infection and alveolar damage in 2228
human lungs. American journal of respiratory and critical care medicine 188:882-886. 2229
190. Chan RW, Chan MC, Agnihothram S, Chan LL, Kuok DI, Fong JH, Guan Y, Poon
2230
LL, Baric RS, Nicholls JM, Peiris JS. 2013. Tropism of and innate immune responses
2231
to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ 2232
cultures. J. Virol. 87:6604-6614. 2233
191. Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, Sun T, Lau CC, Wong KK,
2234
Chan JY, Chan JF, To KK, Chan KH, Zheng BJ, Yuen KY. 2014. Active replication of
2235
Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory 2236
cytokines and chemokines in human macrophages: implications for pathogenesis. J. 2237
126 Infect. Dis. 209:1331-1342.
2238
192. Ziegler AF, Ladman BS, Dunn PA, Schneider A, Davison S, Miller PG, Lu H,
2239
Weinstock D, Salem M, Eckroade RJ, Gelb J, Jr. 2002. Nephropathogenic infectious
2240
bronchitis in Pennsylvania chickens 1997-2000. Avian Dis. 46:847-858. 2241
193. Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, Poon VK, Sun T, Lau CC, Chan
2242
JF, To KK, Chan KH, Lu L, Zheng BJ, Yuen KY. 2014. Productive replication of
2243
Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells 2244
modulates innate immune response. Virology 454-455:197-205. 2245
194. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A,
2246
Alsubaie S, Al-Rabeeah AA, Hajomar WH, Hussain R, Kheyami AM, Almutairi A,
2247
Azhar EI, Drosten C, Watson SJ, Kellam P, Cotten M, Zumla A. 2014. Respiratory
2248
Tract Samples, Viral Load and Genome Fraction Yield in patients with Middle East 2249
Respiratory Syndrome. J. Infect. Dis. 210:1590-1594. 2250
195. de Sousa R, Reusken C, Koopmans M. 2014. MERS coronavirus: data gaps for
2251
laboratory preparedness. J. Clin. Virol. 59:4-11. 2252
196. Cheng VC, Hung IF, Tang BS, Chu CM, Wong MM, Chan KH, Wu AK, Tse DM,
2253
Chan KS, Zheng BJ, Peiris JS, Sung JJ, Yuen KY. 2004. Viral replication in the
2254
nasopharynx is associated with diarrhea in patients with severe acute respiratory 2255
syndrome. Clin. Infect. Dis. 38:467-475. 2256
197. Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen
2257
KY, Peiris JS. 2004. Detection of SARS coronavirus in patients with suspected SARS.
2258
Emerg. Infect. Dis. 10:294-299. 2259
198. Memish ZA, Assiri AM, Al-Tawfiq JA. 2014. Middle East respiratory syndrome
2260
coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational 2261
analysis with infection control implications. Int. J. Infect. Dis. 29:307-308. 2262
199. Palm D, Pereyaslov D, Vaz J, Broberg E, Zeller H, Gross D, Brown CS, Struelens
2263
MJ. 2012. Laboratory capability for molecular detection and confirmation of novel
2264
coronavirus in Europe, November 2012. Euro. Surveill. 17. pii: 20335. 2265
200. Abd El Wahed A, Patel P, Heidenreich D, Hufert FT, Weidmann M. 2013. Reverse
2266
transcription recombinase polymerase amplification assay for the detection of middle 2267
East respiratory syndrome coronavirus. PLoS Curr. 5. pii:
2268
ecurrents.outbreaks.62df1c7c75ffc96cd59034531e2e8364. 2269
201. Shirato K, Yano T, Senba S, Akachi S, Kobayashi T, Nishinaka T, Notomi T,
2270
Matsuyama S. 2014. Detection of Middle East respiratory syndrome coronavirus using
2271
reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol. J. 2272
11:139.
2273
202. Agnihothram S, Gopal R, Yount BL, Jr., Donaldson EF, Menachery VD, Graham
2274
RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS. 2014. Evaluation
2275
of serologic and antigenic relationships between middle eastern respiratory syndrome 2276
coronavirus and other coronaviruses to develop vaccine platforms for the rapid response 2277
to emerging coronaviruses. J. Infec. Dis. 209:995-1006. 2278
203. Chan KH, Chan JF, Tse H, Chen H, Lau CC, Cai JP, Tsang AK, Xiao X, To KK, Lau
2279
SK, Woo PC, Zheng BJ, Wang M, Yuen KY. 2013. Cross-reactive antibodies in
2280
convalescent SARS patients' sera against the emerging novel human coronavirus EMC 2281
(2012) by both immunofluorescent and neutralizing antibody tests. J. Infect. 67:130-140. 2282
204. Cheng VC, Tang BS, Wu AK, Chu CM, Yuen KY. 2004. Medical treatment of viral
127
pneumonia including SARS in immunocompetent adult. J. Infect. 49:262-273. 2284
205. Wong SS, Yuen KY. 2008. The management of coronavirus infections with particular
2285
reference to SARS. J. Antimicrob. Chemother. 62:437-441. 2286
206. Ho PL, Sin WC, Chan JF, Cheng VC, Chan KH. 2014. Severe influenza A H7N9
2287
pneumonia with rapid virological response to intravenous zanamivir. Eur. Respir. J. 2288
44:535-537.
2289
207. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY,
2290
Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM. 2014. Ribavirin and
2291
interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a 2292
retrospective cohort study. Lancet Infect. Dis. 14:1090-1095. 2293
208. Frausto SD, Lee E, Tang H. 2013. Cyclophilins as modulators of viral replication.
2294
Viruses 5:1684-1701. 2295
209. Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H. 2013.
2296
Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b 2297
and ribavirin. Sci. Rep. 3:1686. 2298
210. Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, Li PT, Dai J, Mok FK, Chen
2299